Stroke research at a road block: The streets from adversity should be paved with meta-analysis and good laboratory practice

British Journal of Pharmacology

Volumn 157, Issue 7, 2009, Pages 1154-1156

  Dirnagl, Ulrich ^a   MacLeod, Malcolm R ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Bench to bedside translation; Bias; Good laboratory practice; Meta analysis; Neuroprotection; preclinical; Stroke; Systematic review

Indexed keywords

DISUFENTON SODIUM;

BODY TEMPERATURE; DRUG EFFICACY; DRUG INDUSTRY; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; GOOD LABORATORY PRACTICE; NEUROPROTECTION; NONHUMAN; NOTE; PRIORITY JOURNAL; SCORING SYSTEM; STROKE;

ANIMALS; BENZENESULFONATES; DRUG EVALUATION, PRECLINICAL; FEMALE; MALE; META-ANALYSIS AS TOPIC; NEUROPROTECTIVE AGENTS; STROKE;

EID: 70350339070     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00211.x     Document Type: Note

References (12)

1. Bath PMW, Gray LJ, Bath AJG, Buchan A, Miyata T, Green AR, on behalf of the NXY-059 Efficacy Meta-analysis in individual Animals with Stroke (NEMAS) investigators with Stroke (NEMAS) investigators (2009). Effects of NXY-059 in experimental stroke: an individual animal meta-analysis Br J Pharmacol 157: 1157-1171
2. Crossley NA, Sena E, Goehler J, Horn J, van der Worp B, Bath PM et al. (2008). Empirical evidence of bias in the design of experimental stroke studies: a meta-epidemiological approach. Stroke 39: 929-934
3. Dirnagl U (2006). Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 26: 1465-1478
4. Endres M, Engelhardt B, Koistinaho J, Lindvall O, Meairs S, Mohr JP et al. (2008). Improving outcome after stroke: overcoming the translational roadblock. Cerebrovasc Dis 25: 268-278
5. Fisher M, Feuerstein G, Howells DG, Hurn PD, Kent TA, Savitz SI et al. (2009) Update of the Stroke Therapy Academic Industry Roundtable (STAIR) preclinical recommendations. Stroke [epub ahead of print]
6. Hacke W, Kaste M, Bluhmki E, Brozman M, Dávalos A, Guidetti D et al. (2008). Thrombolysis with alteplase 3 to 4.5 h after acute ischemic stroke. N Engl J Med 359: 1317-1329
7. Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT (2008). Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Med 5 (2): e45
8. Macleod MR, van der Worp HB, Sena ES, Howells DW, Dirnagl U, Donnan GA (2008). Evidence for the efficacy of NXY-059 in experimental focal cerebral ischaemia is confounded by study quality. Stroke 39: 2824-2829
9. Macleod MR, Fisher M, O'Collins V, Sena ES, Dirnagl U, Bath PM et al. (2009). Preventing Introduction of Bias at the Bench. J Cereb Blood Flow Metab 29: 221-223
10. Savitz SI (2007). A critical appraisal of the NXY-059 neuroprotection studies for acute stroke: a need for more rigorous testing of neuro-protective agents in animal models of stroke. Exp Neurol 205: 20-25
11. Shuaib A, Lees KR, Lyden P, Grotta J, Davalos A, Davis SM et al. (2007). NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357: 562-571
12. Stroke therapy academic industry roundtable (Fisher M, Chair) (1999). Recommendations for standards regarding preclinical neuro-protective and restorative drug development. Stroke 30: 2752-2758